Table 3.
ER | HbT | %Hb_EOC1 | %HbT_EOC2 | %HbT_EOC3 | US | %US_EOC1 | %US_EOC2 | %US_EOC3 | |
---|---|---|---|---|---|---|---|---|---|
| |||||||||
HER2 | −0.293 | 0.263 | − 0.052 | − 0.114 | − 0.386 | 0.118 | − 0.404 | − 0.241 | − 0.130 |
ER | 0.171 | − 0.129 | − 0.210 | − 0.196 | − 0.191 | − 0.164 | − 0.222 | − 0.269 | |
TN | 0.000 | − 0.154 | − 0.194 | − 0.131 | − 0.305 | 0.099 | 0.016 | − 0.135 | |
HbT | − 0.449 | − 0.582 | − 0.463 | − 0.015 | − 0.167 | − 0.180 | 0.234 | ||
%HbT_EOC1 | 0.701 * | 0.641 | 0.151 | − 0.076 | 0.037 | 0.104 | |||
%HbT_EOC2 | 0.644 | − 0.039 | 0.192 | 0.142 | 0.239 | ||||
%HbT_EOC3 | 0.202 | 0.282 | 0.220 | 0.399 | |||||
US | − 0.111 | − 0.178 | − 0.060 | ||||||
%US_EOC1 | 0.792 | 0.641 | |||||||
%US_EOC2 | 0.875 | ||||||||
%US EOC3 |
Data were from this study of total 38 patients
The high correlation coefficients occur between %HbT_EOC1, %HbT_EOC2 and %HbT_EOC3, and between %US_EOC1, %US_EOC2, and %US_EOC3